H Mo

Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor

D. Ho, M. Markowitz, H. Mo, 1997, Antimicrobial agents and chemotherapy.

Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor

D. Ho, T. Bhat, M. Markowitz, 1995, Journal of virology.

Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

D. Ho, Y. Cao, R. Koup, 1993, Science.

Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor

D Norbeck, D. Ho, D. Norbeck, 1994, Journal of virology.

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease

D. Ho, M. Markowitz, H. Mo, 1996, Antimicrobial agents and chemotherapy.

Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off

D R Burton, C. Barbas, J. Moore, 1997, Journal of virology.

Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood.

J. Moore, D. Ho, J. Hoxie, 1998, AIDS research and human retroviruses.